Communiqués de presse

News Center

Le groupe Eurobio Scientific acquiert les actifs de l'unité Life Science de Voden Medical Instruments S.p.A.

We are pleased to announce the signing of an agreement on March 11, 2025, to acquire the assets of the Life Science unit of Voden Medical Instruments S.p.A. This unit focuses on diagnostics, cellular and molecular biology as well as genome analysis and distributes our GenDx line of products in Italy. These strategic acquisitions strengthen […]

Le groupe Eurobio Scientific acquiert les actifs de l'unité Life Science de Voden Medical Instruments S.p.A. Lire plus "

Le groupe Eurobio Scientific a finalisé avec succès l'acquisition de Quimark SRL

As of March 1st, 2025, Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL, our trusted distributor of 𝐄𝐧𝐝𝐨𝐏𝐫𝐞𝐝𝐢𝐜𝐭® and 𝐏𝐫𝐨𝐥𝐚𝐫𝐢𝐬® in Italy. This strategic step strengthens our presence in the Italian market and reaffirms our commitment to providing innovative oncology solutions to patients and healthcare professionals. We look forward to this new

Le groupe Eurobio Scientific a finalisé avec succès l'acquisition de Quimark SRL Lire plus "

Eurobio Scientific élargit son portefeuille de produits d'oncologie grâce à un partenariat avec Biovica

Eurobio Scientific has signed a strategic agreement with Biovica, a company specializing in cancer monitoring, to distribute DiviTum® TKa in key European markets, including DACH, UK, FR and Benelux. This collaboration covers 60% of the European market potential and strengthens Eurobio Scientific’s oncology diagnostics offering. DiviTum® TKa is a blood-based biomarker test that monitors and predicts

Eurobio Scientific élargit son portefeuille de produits d'oncologie grâce à un partenariat avec Biovica Lire plus "

fr_FR
Retour en haut